• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

Dossier.org

Market Intelligence

  • About
    • How to structure intent in Memorandum of Understanding (MOU)
  • Market Dossier
    • Technology Dossier
    • Events
    • Venture Capital Dossier
  • Domain Dossier
  • Sponsored Post
    • Make a Contribution
  • Contact

Inflazome IP Portfolio Strengthened with Patents Granted in US and Europe

January 13, 2020 By admin Leave a Comment

Inflazome (inflazome.com), the pioneering inflammasome biotech company developing multiple small molecule drugs that block harmful inflammation, today announces that the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO) will grant the patent application WO 2016/131098 as US 10,538,487 on 21 January 2020 and EP 3,259,253 on 15 January 2020.

The patents provide for compounds which have advantageous properties and show useful activity in the inhibition of NLRP3 inflammasome activation. Such compounds are useful in the treatment of a wide range of disorders, including Parkinson’s, Alzheimer’s and Motor Neuron Disease, in which inflammation arising from the NLRP3 inflammasome is implicated as a key factor. Inflazome currently has two ongoing Phase I studies with Inzomelid and Somalix.

These new patents strengthen Inflazome’s intellectual property portfolio that extends to 43 patent families, reinforcing the company’s leading innovative position in discovering targeted therapies for inflammatory-driven diseases.

Matt Cooper, Chief Executive Officer of Inflazome, commented: “The granting of these pioneering patents marks another milestone for Inflazome and strengthens our IP portfolio. The patents granted in the US and Europe cover our lead clinical candidate, Inzomelid. Both Inzomelid and our second drug, Somalix, are in the final stages of Phase I safety and tolerability trials for inflammatory diseases. We look forward to driving these drugs into further trials to help people with debilitating diseases.”

The patent was originally filed by the University of Queensland and Trinity College Dublin following a highly productive collaboration between Inflazome founders, Professor Matt Cooper (University of Queensland) and Professor Luke O’Neill (Trinity College Dublin). It was licensed exclusively to Inflazome when the company was founded.

About Inflazome
Inflazome is a biotech company leading the development of orally available drugs to address clinical unmet needs in inflammatory diseases by targeting inflammasomes. Inflammasomes are understood to drive many chronic inflammatory conditions, from Parkinson’s and Alzheimer’s to asthma, inflammatory bowel disease, chronic kidney disease, cardiovascular disease, arthritis and NASH. Inflazome has two ongoing Phase I studies, the first with Inzomelid which is under development as an orally available, brain-penetrant drug, and the second with Somalix which is under development as an orally available, peripherally-restricted drug to address clinical unmet needs in inflammatory conditions. Inflazome is headquartered in Dublin, Ireland, with offices in Cambridge, UK and Brisbane, Australia.

To learn more visit: inflazome.com

About the NLPR3 Inflammasome
Activated NLRP3 acts as a ‘danger sensor’ in the body to release the pro-inflammatory cytokines IL-1β, IL-18 and induce uncontrolled, lytic cell death (pyroptosis). These processes lead to chronic inflammation, and as such, NLRP3 has been implicated in a large number of diseases.

Filed Under: News Tagged With: IP Portfolio, Inflazome, NLPR3 Inflammasome, patent research

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

VC

Token Announces $13 Million Series B Funding Round and Appointment of New CEO to Disrupt the Authentication Market
After Successful Tax Season, Embedded Tax Platform April Raises $30M Series A from Fintech Veterans
Vita Mojo Raises US$30 Million to Help Restaurant and Hospitality Chains in Europe Tackle the Digital Future
Blockchain co Starkware raises $100m at $8b valuation
Cloudflare Announces $1.25 Billion “Workers Launchpad” Funding Program to Help Startups Grow Their Businesses
Janngo Capital Startup Fund, Africa’s largest gender equal tech VC fund, reaches the first close of its €60 million new fund
Katana Closes $35M Series B to Scale an Industry-Leading Manufacturing Ecosystem for SMBs

Technologies

5G is the New Cyber Attack Surface: Understanding the Risks and Opportunities
China’s Quest for Indigenized Semiconductor Production: Hurdles and Challenges Ahead
Revolutionizing the Fashion Industry: Algae-based Yarns and Dyes Take on Fast Fashion
DLD 2023 is coming
Top Technology Trends of 2022
The Progress and Promise of AI Music Generation
Reducing Waste, Saving Energy: How Water Companies Can Recycle Residual Heat Energy

Secondary Sidebar

Analysis

Probability of the world economy succumbing to a recession is nearing 50%
The global supply squeeze
More Than a Quarter of C-level Execs Unaware of Low-code, No-Code Revolution, According to CLEVR Survey
Explosive E-Commerce Growth Driving Tech Investments in Supply Chain Execution Systems and High ROI According to New Blue Yonder and Reuters Events Supply Chain Report
VC Funding Digest

Market Research

Top Ten Trends for the Future of Digital Media in 2023 and Beyond
A six-step forecasting methodology
MoscowRules.com (Moscow Rules): A Perfect Title for Publication Covering Russian Affairs
Smart Media Streamer is Better Than Smart TV
What is adaptable marketing strategy?

Footer

Recent Posts

  • Why UK faces chronic labor shortages
  • Battery Ventures Announces Sale of Physical-Security Technology Firm Qognify to Hexagon AB
  • impak Ratings acquires Exerica, a London-based fintech data extraction firm
  • Kentucky’s Wilderness Trail bourbon distillery to be sold to Italian maker of Campari
  • Container xChange Survey: 60% of Freight Forwarders and NVOCCs Struggle to Monitor Movement of Shipping Containers
  • Cloud storage company Box can surge nearly 40% on the future of work
  • Rockwell Automation Announces Intent to Acquire CUBIC
  • Vianode invests NOK 2 billion in battery materials plant in Norway
  • 69% of investors are betting the euro will slide to $0.9
  • Defense Market, July 2022

RSS Blockchaining

  • Blockchain topics to be covered at DLD 2023
  • Experience the Future of Blockchain at Cybertech 2023
  • Join Our Team as a Blockchain Developer - Revolutionize the Future
  • The Fascinating World of Cryptocurrency
  • State of Technology Overview: Blockchaining 2023

RSS S3H

  • Embracing Disruptive Innovation: The Key to a Better Future
  • The future of IoT and its impact on our lives and our world
  • Securing the Future: The Importance of Strong Cybersecurity
  • Cybertech 2023
  • Join Our Team at S3H.com Consulting - A One-Stop Shop for Technology Solutions

RSS VPNW

  • Unlock Your Creativity with a Competitive Mindset
  • Start today and make exercise a part of your daily routine
  • If hard work meant success, the donkey would own the farm
  • The Benefits of Mindfulness Meditation
  • The Rise of Plant-Based Diets

RSS OPINT

  • North Korea is working to create a nuclear warfighting capability
  • China’s proliferation of nuclear and missile-related technologies to other countries
  • The United States has been a major supporter of Ukraine’s security
  • The Impact of the Middle East on Global Geopolitics
  • The Impact of the Belt and Road Initiative on Global Geopolitics

Copyright © 2022 Dossier.org

Technologies, Market Analysis & Market Research and Exclusive Domains

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT